These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15974449)

  • 21. Population pharmacokinetics of gentamicin and dosing optimization for infants.
    Medellín-Garibay SE; Rueda-Naharro A; Peña-Cabia S; García B; Romano-Moreno S; Barcia E
    Antimicrob Agents Chemother; 2015 Jan; 59(1):482-9. PubMed ID: 25385111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of gentamicin in premature newborns.
    García B; Barcia E; Pérez F; Molina IT
    J Antimicrob Chemother; 2006 Aug; 58(2):372-9. PubMed ID: 16782742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition.
    Seaton C; Ignas J; Muchohi S; Kokwaro G; Maitland K; Thomson AH
    J Antimicrob Chemother; 2007 Apr; 59(4):681-9. PubMed ID: 17347177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing.
    Xuan D; Nicolau DP; Nightingale CH
    Int J Antimicrob Agents; 2004 Mar; 23(3):291-5. PubMed ID: 15164971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A priori prediction of gentamicin peak concentrations: Use of a simple and practical tool].
    Mignaval F; Fontaine PA; Riché A; Nowak C; Cancel D; Lemaitre F
    Pathol Biol (Paris); 2011 Apr; 59(2):79-82. PubMed ID: 20822863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of two gentamicin dosing schedules in very low birth weight infants.
    Rastogi A; Agarwal G; Pyati S; Pildes RS
    Pediatr Infect Dis J; 2002 Mar; 21(3):234-40. PubMed ID: 12005088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates.
    Stolk LM; Degraeuwe PL; Nieman FH; de Wolf MC; de Boer A
    Ther Drug Monit; 2002 Aug; 24(4):527-31. PubMed ID: 12142638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The "Ideal" Body Weight for Pediatric Gentamicin Dosing in the Era of Obesity: A Population Pharmacokinetic Analysis.
    Moffett BS; Kam C; Galati M; Schmees L; Stitt GA; Revell PA; Palazzi DL
    Ther Drug Monit; 2018 Jun; 40(3):322-329. PubMed ID: 29521784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gentamicin pharmacokinetics in Thai neonates: recommendation for a dosing guideline.
    Kanthawatana S; Uruwannakul K; Chotinarumon S
    J Med Assoc Thai; 1998 Feb; 81(2):136-40. PubMed ID: 9529844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.
    Kirkpatrick CM; Duffull SB; Begg EJ
    Br J Clin Pharmacol; 1999 Jun; 47(6):637-43. PubMed ID: 10383541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of estimating individual pharmacokinetic data for aminoglycoside therapy in seriously ill patients.
    Denaro CP; Ravenscroft PJ
    Aust N Z J Med; 1987 Oct; 17(5):526-32. PubMed ID: 3446165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standard gentamicin dosage regimen in neonates.
    Langlass TM; Mickle TR
    Am J Health Syst Pharm; 1999 Mar; 56(5):440-3. PubMed ID: 10096704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia.
    Panidis D; Markantonis SL; Boutzouka E; Karatzas S; Baltopoulos G
    Chest; 2005 Aug; 128(2):545-52. PubMed ID: 16100136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
    Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
    Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population Pharmacokinetics and Dosing Considerations for Gentamicin in Newborns with Suspected or Proven Sepsis Caused by Gram-Negative Bacteria.
    Bijleveld YA; van den Heuvel ME; Hodiamont CJ; Mathôt RA; de Haan TR
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of four once-daily aminoglycoside dosing nomograms.
    Wallace AW; Jones M; Bertino JS
    Pharmacotherapy; 2002 Sep; 22(9):1077-83. PubMed ID: 12222541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of diagnostic and treatment factors in the population pharmacokinetics of gentamicin.
    Romano S; González P; Tejada P; Antón J; Aguado JM; Lanao JM
    J Clin Pharm Ther; 1998 Apr; 23(2):141-8. PubMed ID: 9786101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The kinetic profile of gentamicin in premature neonates.
    Rocha MJ; Almeida AM; Afonso E; Martins V; Santos J; Leitão F; Falcão AC
    J Pharm Pharmacol; 2000 Sep; 52(9):1091-7. PubMed ID: 11045889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminoglycoside forecasting in neutropenic patients with cancer.
    Kosirog JL; Rospond RM; Destache C; Hall P
    Clin Pharmacokinet; 1993 Jan; 24(1):79-87. PubMed ID: 8448975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.